Pharmacogenomics of anticancer drugs: Personalising the choice and dose to manage drug response. (2021)
Attributed to:
Centre for Drug Safety Science (CDSS)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/bcp.14407
PubMed Identifier: 32501544
Publication URI: http://europepmc.org/abstract/MED/32501544
Type: Journal Article/Review
Volume: 87
Parent Publication: British journal of clinical pharmacology
Issue: 2
ISSN: 0306-5251